sales@futurewiseresearch.com
UK : +44 141 628 9353 / US : +1 347 709 4931
Get In Touch
Home
Why Work With Us
Services
Consulting Services
Market Analysis
Competative Analysis
Full-Time Engagement
Reports
Healthcare
Medical Device
Biotechnology
Pharmaceutical
Healthcare IT
Drug Discovery
Vaccines
Pharmaceutical Packaging
Genetics
Genomics
Diagnostics
Animal Health
Others
Media
Press Release
In The News
Latest Market Insights
Glaucoma Treatment Market By Indication, By Drug Class and By Region: Industry Analysis, Market Share, Revenue Opportunity, Competitive Analysis and Forecast 2020-2027
Published :
Report Code :
HC-U2241
Category :
Healthcare
Tables :
45
Figures :
42
No. of Pages :
214
Request Sample
Ask an Analyst
Request for TOC
Report Overview
Table of Contents
List of Tables
List of figures
Overview
Glaucoma Treatment Market Segmentation:
Glaucoma Treatment Market is poised to have a CAGR of over 4.6% during the forecast period 2020 to 2027.
FutureWise Market Research has illustrated a report on the Glaucoma Treatment Market. The report provides an in-depth anatomy of the market trends affecting its growth. Moreover, it includes intricate insights on profitability graph, market share, SWOT analysis and geographical augmentation of this business. Furthermore, the report provides information on the status of key market players in the competitive landscape analysis of this market.
The Glaucoma Treatment Market is projected to achieve significant growth by the end of the forecast period as per the research study conducted by FutureWise research analysts. The report explains that this business is predicted to record a remarkable growth rate over the forecast period. This report provides important information regarding the total valuation that this industry holds presently and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Major players included in the Glaucoma Treatment market are
• Aerie Pharmaceuticals Inc.
• Akorn, Incorporated
• Abbvie Inc. (Allergan Plc)
• Bausch Health (Bausch
Lomb Incorporated)
• Inotek Pharmaceuticals
• MerckCo., Inc.
• Novartis AG
• Pfizer Inc
• Santen Pharmaceutical Co., Ltd.
(Note: The list of the major players will be updated with the latest market scenario and trends)
By Indication
• Open Angle Glaucoma
• Closed Angle Glaucoma
• Secondary Glaucoma
• Congenital Glaucoma
• Others
By Drug Class
• Prostaglandin Analogs
• Beta Blockers
• Alpha Agonist
• Carbonic Anhydrase Inhibitors
• Others
By Region
• North America
•
Europe
• Asia-Pacific
• Rest of the world
Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants
FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the Glaucoma Treatment Market By Indication, By Drug Class and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America,
Europe
, Asia Pacific and rest of the world
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization services offered are free of charge with purchase of any license of the report.
• You can directly share your requirements/changes to the current table of content to:
sales@futurewiseresearch.com
Table of Contents
1. Market Introduction
1. Objectives of the Study
2. Market Definition
3. Market Scope
3.1. Years Considered for the Study
3.2. Market Covered
4. Currency
5. Limitations
6. Stakeholders
2. Research Methodology
1. Research Data
1.1. Secondary Data
1.1.1. Key Data from Secondary Sources
1.2. Primary Data
1.2.1. Key Data from Primary Sources
2. Market Size Estimation
3. Market Breakdown and Data Triangulation
4. Assumptions for the Study
3. Executive Summary
1. Market Outlook
2. Segment Outlook
3. Competitive Insights
4. Global Glaucoma Treatment Market Variables, Trends
Scope
1. Market Lineage Outlook
2. Penetration and Growth Prospect Mapping
3. Industry Value Chain Analysis
4. Cost Analysis Breakdown
5. Technology Overview
6. Regulatory Framework
6.1. Reimbursement Framework
6.2. Standards and Compliances
5. Market Overview
1. Market Dynamics
1.1. Market Driver Analysis
1.1.1. Increasing focus of Glaucoma Treatment Companies on Brand Protection
1.1.2. Untapped Opportunities in Emerging Regions
1.2. Market Restraint Analysis
1.2.1. High Cost Associated with Implementation of Predictive Analysis
1.3. Industry Challenges
1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Glaucoma Treatment Market Analysis Tools
1. Industry Analysis - Porter’s
1.1. Supplier Power
1.2. Buyer Power
1.3. Substitution Threat
1.4. Threat from New Entrants
1.5. Competitive Rivalry
2. Pestel Analysis
2.1. Political Landscape
2.2. Environmental Landscape
2.3. Social Landscape
2.4. Technology Landscape
2.5. Legal Landscape
3. Major Deals And Strategic Alliances Analysis
3.1. Joint Ventures
3.2. Mergers and Acquisitions
3.3. Licensing and Partnership
3.4. Technology Collaborations
3.5. Strategic Divestments
4. Market Entry Strategies
5. Case Studies
7. Global Glaucoma Treatment Market, By Indication Historical Analysis and Forecast 2020-2027 (USD Million)
1. Open Angle Glaucoma
2. Closed Angle Glaucoma
3. Secondary Glaucoma
4. Congenital Glaucoma
5. Others
8. Global Glaucoma Treatment Market, By Drug Class Historical Analysis and Forecast 2020-2027 (USD Million)
1. Prostaglandin Analogs
2. Beta Blockers
3. Alpha Agonist
4. Carbonic Anhydrase Inhibitors
5. Others
9. North America Glaucoma Treatment Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
1. Introduction
2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
2.1. U.S.A
2.2. Canada
2.3. Mexico
3. Market Size (USD Million) Forecast for North America 2020-2027
10. Latin America Glaucoma Treatment Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
1. Introduction
2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
2.1. Brazil
2.2. Venezuela
2.3. Argentina
2.4. Rest of Latin America
3. Market Size (USD Million) Forecast for Latin America 2020-2027
11. Europe Glaucoma Treatment Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
1. Introduction
2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
2.1. Germany
2.2. U.K
2.3. France
2.4. Italy
2.5. Spain
2.6. Russia
2.7. Poland
2.8. Rest of Europe
3. Market Size (USD Million) Forecast for Europe 2020-2027
12. Asia Pacific Glaucoma Treatment Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
1. Introduction
2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
2.1. Japan
2.2. China
2.3. India
2.4. Australia and New Zealand
2.5. ASEAN
2.6. Rest of Asia Pacific
3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
13. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
1. Introduction
2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
2.1. Saudi Arabia
2.2. UAE
2.3. South Africa
2.4. Egypt
3. Market Size (USD Million) Forecast for MEA 2020-2027
14. Market Share Analysis and Competitive Landscape
1. Global Landscape - Key Players, Revenue and Presence
2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
3. Global Emerging Companies
4. North America - Market Share Analysis and Key Regional Players
5. Europe - Market Share Analysis and Key Regional Players
6. Asia Pacific - Market Share Analysis and Key Regional Players
7. Global Key Player - Growth Matrix
15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
1. Aerie Pharmaceuticals Inc.
1.1. Company Overview
1.2. Product Portfolio
1.3. SWOT Analysis
1.4. Financial Overview
1.5. Strategic Overview
2. Akorn, Incorporated
2.1. Company Overview
2.2. Product Portfolio
2.3. SWOT Analysis
2.4. Financial Overview
2.5. Strategic Overview
3. Abbvie Inc. (Allergan Plc)
3.1. Company Overview
3.2. Product Portfolio
3.3. SWOT Analysis
3.4. Financial Overview
3.5. Strategic Overview
4. Bausch Health (Bausch
16. Lomb Incorporated).
15.4.1. Company Overview
15.4.2. Product Portfolio
15.4.3. SWOT Analysis
15.4.4. Financial Overview
15.4.5. Strategic Overview
15.5. Inotek Pharmaceuticals
15.5.1. Company Overview
15.5.2. Product Portfolio
15.5.3. SWOT Analysis
15.5.4. Financial Overview
15.5.5. Strategic Overview
15.6. MerckCo., Inc.
15.6.1. Company Overview
15.6.2. Product Portfolio
15.6.3. SWOT Analysis
15.6.4. Financial Overview
15.6.5. Strategic Overview
15.7. Novartis AG
15.7.1. Company Overview
15.7.2. Product Portfolio
15.7.3. SWOT Analysis
15.7.4. Financial Overview
15.7.5. Strategic Overview
15.8. Pfizer Inc.
15.8.1. Company Overview
15.8.2. Product Portfolio
15.8.3. SWOT Analysis
15.8.4. Financial Overview
15.8.5. Strategic Overview
15.9. Santen Pharmaceutical Co., Ltd.
15.9.1. Company Overview
15.9.2. Product Portfolio
15.9.3. SWOT Analysis
15.9.4. Financial Overview
15.9.5. Strategic Overview
17. Pre and Post COVID-19 Impact
16.1. Positive influence on the healthcare industry
16.2. The financial disruption of the manufacturing sector
16.3. Impact of COVID-19 on emerging companies
16.4. Significant mandates in the healthcare regulations initiated by administrations
16.5. The overall economic slowdown of the developing and developed nations
18. FutureWise SME Key Takeaway Points for Client
Report Overview
Table of Contents
List of Tables
List of figures
Data Pack license:
Data Pack license:
$1250
Single user license:
Single user license:
$2850
Multi user license:
Multi user license:
$3850
Corporate license:
Corporate license:
$5000
Ask for Discount
Buy Now
Customize This Report
We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.
Need Assistance
UK : +44 141 628 9353
US : +1 347 709 4931
What you get
Excel Dataset
Market Overview
Infographics
PowerPoint Presentation
PDF Report
What's included
Consumer Perception and Procurement
Market Data Forecast
Competitive Analysis
Risks and Opportunity Assessment
Market Trends and Dynamics
Partner
Our Clients